메뉴 건너뛰기




Volumn 21, Issue 2, 2014, Pages

Patients' perceptions of gene expression profiling in breast cancer treatment decisions

Author keywords

Breast cancer; Chemotherapy; Decision making; Gene expression profiling; Genomics; Patient perceptions; Personalized medicine; Risk recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER THERAPY; CLINICAL ARTICLE; DECISION MAKING; EMOTIONAL DISORDER; EMPOWERMENT; FEMALE; GENE EXPRESSION PROFILING; HEALTH CARE COST; HEALTH CARE SURVEY; HUMAN; INFORMATION PROCESSING; INTERVIEW; MIDDLE AGED; PATIENT ATTITUDE; PATIENT EDUCATION;

EID: 84898817552     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.1524     Document Type: Article
Times cited : (24)

References (29)
  • 1
    • 39149113165 scopus 로고    scopus 로고
    • Development of the 21-gene assay and its application in clinical practice and clinical trials
    • Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 2008;26:721-8
    • (2008) J Clin Oncol , vol.26 , pp. 721-728
    • Sparano, J.A.1    Paik, S.2
  • 2
    • 34247516968 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network (nccn), Ver. 1.2010. Fort Washington, PA: nccn
    • National Comprehensive Cancer Network (nccn). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Ver. 1.2010. Fort Washington, PA: nccn; 2010
    • (2010) NCCN Clinical Practice Guidelines In Oncology: Breast Cancer
  • 4
    • 70450190156 scopus 로고    scopus 로고
    • Canadian Cancer Society and the National Cancer Institute of Canada, Toronto, ON: Canadian Cancer Society
    • Canadian Cancer Society and the National Cancer Institute of Canada. Canadian Cancer Statistics 2008. Toronto, ON: Canadian Cancer Society; 2008
    • (2008) Canadian Cancer Statistics 2008
  • 5
    • 34347356514 scopus 로고    scopus 로고
    • Current St Gallen recommendations on primary therapy of early breast cancer
    • Persing M, Grosse R. Current St Gallen recommendations on primary therapy of early breast cancer. Breast Care (Basel) 2007;2:137-40
    • (2007) Breast Care (Basel) , vol.2 , pp. 137-140
    • Persing, M.1    Grosse, R.2
  • 6
    • 19944422061 scopus 로고    scopus 로고
    • A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    • Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-26
    • (2004) N Engl J Med , vol.351 , pp. 2817-2826
    • Paik, S.1    Shak, S.2    Tang, G.3
  • 7
    • 33748693297 scopus 로고    scopus 로고
    • Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
    • Buyse M, Loi S, van't Veer L, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98:1183-92
    • (2006) J Natl Cancer Inst , vol.98 , pp. 1183-1192
    • Buyse, M.1    Loi, S.2    Van't veer, L.3
  • 8
    • 0037137519 scopus 로고    scopus 로고
    • A gene-expression signature as a predictor of survival in breast cancer
    • van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009
    • (2002) N Engl J Med , vol.347 , pp. 1999-2009
    • van de Vijver, M.J.1    He, Y.D.2    Van't veer, L.J.3
  • 9
    • 34249052585 scopus 로고    scopus 로고
    • Predicting response to primary chemotherapy: Gene expression profiling of paraffin-embedded core biopsy tissue
    • Mina L, Soule SE, Badve S, et al. Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. Breast Cancer Res Treat 2007;103:197-208
    • (2007) Breast Cancer Res Treat , vol.103 , pp. 197-208
    • Mina, L.1    Soule, S.E.2    Badve, S.3
  • 10
    • 33750598939 scopus 로고    scopus 로고
    • The hoxb13:Il17br expression index is a prognostic factor in early-stage breast cancer
    • Ma XJ, Hilsenbeck SG, Wang W, et al. The hoxb13:il17br expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 2006;24:4611-19
    • (2006) J Clin Oncol , vol.24 , pp. 4611-4619
    • Ma, X.J.1    Hilsenbeck, S.G.2    Wang, W.3
  • 11
    • 33750895236 scopus 로고    scopus 로고
    • Tailorx: Trial assigning individualized options for treatment (Rx)
    • Sparano JA. tailorx: trial assigning individualized options for treatment (Rx). Clin Breast Cancer 2006;7: 347-50
    • (2006) Clin Breast Cancer , vol.7 , pp. 347-350
    • Sparano, J.A.1
  • 12
    • 33947196825 scopus 로고    scopus 로고
    • Impact of a 21-gene rt-pcr assay on t reatment decisions i n early-stage breast cancer: An economic analysis based on prognostic and predictive validation studies
    • Lyman GH, Cosler LE, Kuderer NM, Hornberger J. Impact of a 21-gene rt-pcr assay on t reatment decisions i n early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies. Cancer 2007;109:1011-18
    • (2007) Cancer , vol.109 , pp. 1011-1018
    • Lyman, G.H.1    Cosler, L.E.2    Kuderer, N.M.3    Hornberger, J.4
  • 13
    • 59849127767 scopus 로고    scopus 로고
    • Recommendations from the egapp Working Group: Can tumor gene expression profiling improve outcomes in patients with breast cancer?
    • Evaluation of Genomic Applications in Practice and Prevention (egapp) Working Group
    • Evaluation of Genomic Applications in Practice and Prevention (egapp) Working Group. Recommendations from the egapp Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Genet Med 2009;11:66-73
    • (2009) Genet Med , vol.11 , pp. 66-73
  • 14
    • 85168679425 scopus 로고    scopus 로고
    • Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: An evidence-based and economic analysis
    • Health Quality Ontario
    • Health Quality Ontario. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Ont Health Technol Assess Ser 2010;10:1-57
    • (2010) Ont Health Technol Assess Ser , vol.10 , pp. 1-57
  • 17
    • 36849069347 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    • Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25:5287-312
    • (2007) J Clin Oncol , vol.25 , pp. 5287-5312
    • Harris, L.1    Fritsche, H.2    Mennel, R.3
  • 18
    • 52049089470 scopus 로고    scopus 로고
    • Does Oncotype dx recurrence score affect the management of patients with earlystage breast cancer?
    • Asad J, Jacobson AF, Estabrook A, et al. Does Oncotype dx recurrence score affect the management of patients with earlystage breast cancer? Am J Surg 2008;196:527-9
    • (2008) Am J Surg , vol.196 , pp. 527-529
    • Asad, J.1    Jacobson, A.F.2    Estabrook, A.3
  • 19
    • 42649098952 scopus 로고    scopus 로고
    • Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer
    • Oratz R, Paul D, Cohn AL, Sedlacek SM. Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer. J Oncol Pract 2007;3:182-6
    • (2007) J Oncol Pract , vol.3 , pp. 182-186
    • Oratz, R.1    Paul, D.2    Cohn, A.L.3    Sedlacek, S.M.4
  • 20
    • 77950494285 scopus 로고    scopus 로고
    • Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
    • Lo SS, Mumby PB, Norton J, et al. Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol 2010;28:1671-6
    • (2010) J Clin Oncol , vol.28 , pp. 1671-1676
    • Lo, S.S.1    Mumby, P.B.2    Norton, J.3
  • 21
    • 65449138790 scopus 로고    scopus 로고
    • The influence of a gene expression profile on breast cancer decisions
    • Henry LR, Stojadinovic A, Swain SM, et al. The influence of a gene expression profile on breast cancer decisions. J Surg Oncol 2009;99:319-23
    • (2009) J Surg Oncol , vol.99 , pp. 319-323
    • Henry, L.R.1    Stojadinovic, A.2    Swain, S.M.3
  • 22
    • 35648995985 scopus 로고    scopus 로고
    • Women's interest in gene expression analysis for breast cancer recurrence risk
    • O'Neill SC, Brewer NT, Lillie SE, et al. Women's interest in gene expression analysis for breast cancer recurrence risk. J Clin Oncol 2007;25:4628-34
    • (2007) J Clin Oncol , vol.25 , pp. 4628-4634
    • O'Neill, S.C.1    Brewer, N.T.2    Lillie, S.E.3
  • 23
    • 84859916611 scopus 로고    scopus 로고
    • Knowledge about genomic recurrence risk testing among breast cancer survivors
    • Lipkus IM, Vadaparampil ST, Jacobsen PB, Miree CA. Knowledge about genomic recurrence risk testing among breast cancer survivors. J Cancer Educ 2011;26:664-9
    • (2011) J Cancer Educ , vol.26 , pp. 664-669
    • Lipkus, I.M.1    Vadaparampil, S.T.2    Jacobsen, P.B.3    Miree, C.A.4
  • 24
    • 77951019146 scopus 로고    scopus 로고
    • Women's experiences with genomic testing for breast cancer recurrence risk
    • Tzeng JP, Mayer D, Richman AR, et al. Women's experiences with genomic testing for breast cancer recurrence risk. Cancer 2010;116:1992-2000
    • (2010) Cancer , vol.116 , pp. 1992-2000
    • Tzeng, J.P.1    Mayer, D.2    Richman, A.R.3
  • 26
    • 33847752170 scopus 로고    scopus 로고
    • Retention and use of breast cancer recurrence risk information from genomic tests: The role of health literacy
    • Lillie SE, Brewer NT, O'Neill SC, et al. Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy. Cancer Epidemiol Biomarkers Prev 2007;16:249-55
    • (2007) Cancer Epidemiol Biomarkers Prev , vol.16 , pp. 249-255
    • Lillie, S.E.1    Brewer, N.T.2    O'Neill, S.C.3
  • 27
    • 69049109085 scopus 로고    scopus 로고
    • When genomic and standard test results diverge: Implications for breast cancer patients' preference for chemotherapy
    • Brewer NT, Edwards AS, O'Neill SC, Tzeng JP, Carey LA, Rimer BK. When genomic and standard test results diverge: implications for breast cancer patients' preference for chemotherapy. Breast Cancer Res Treat 2009;117:25-9
    • (2009) Breast Cancer Res Treat , vol.117 , pp. 25-29
    • Brewer, N.T.1    Edwards, A.S.2    O'Neill, S.C.3    Tzeng, J.P.4    Carey, L.A.5    Rimer, B.K.6
  • 28
    • 84857038599 scopus 로고    scopus 로고
    • Tailored chemotherapy based on tumour gene expression analysis: Breast cancer patients' misinterpretations and positive attitudes
    • Pellegrini I, Rapti M, Extra JM, et al. Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes. Eur J Cancer Care (Engl) 2012;21:242-50
    • (2012) Eur J Cancer Care (Engl) , vol.21 , pp. 242-250
    • Pellegrini, I.1    Rapti, M.2    Extra, J.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.